Tactic Pharma LLC

Chief Executive Officer at MNPR

Sold, on record
$36.8M
Dollars the filings state
Form 4 sales
2
Latest Sep 24, 2025
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • MNPRMonopar TherapeuticsChief Executive Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale MNPRUnusual
    Feb 11, 2021 2021

    Sold 125,000 shares at $14.64 ($1.8M)

    Tactic Pharma LLC, 10% owner

    Sold 42.9% of holdings ($4.3M position)166,667 shares leftFirst sale on recordFiling

  2. 2 Form 144 notice MNPRNotice
    Apr 2, 2025 +1511 days

    Filed to sell 33,334 shares ($1.2M)

    Tactic Pharma LLC, 10% Stockholder

    No 10b5-1 planFirst sale on recordFiling

  3. 3 Form 4 sale MNPRUnusual
    Sep 24, 2025 +175 days

    Sold 550,229 shares at $63.61 ($35M)

    Tactic Pharma LLC, Chief Executive Officer

    No 10b5-1 planSold 66.9% of holdings ($52.3M position)272,026 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Tactic Pharma LLC
Source
Sep 24, 2025Sep 26, 2025MNPRChief Executive OfficerForm 4 sale550,229$35M66.9%UnusualSEC
Apr 2, 2025Apr 2, 2025MNPR10% StockholderForm 144 notice33,334$1.2MNoticeSEC
Feb 11, 2021Feb 16, 2021MNPR10% ownerForm 4 sale125,000$1.8M42.9%UnusualSEC